Molybdenum Nanoparticles Ameliorate Psoriatic Lesions by Inhibiting the ROS/NF-κb Signaling Axis-Reference-Cited by-同舟云学术

Molybdenum Nanoparticles Ameliorate Psoriatic Lesions by Inhibiting the ROS/NF-κb Signaling Axis

Published:2024-05-23 Issue:11 Volume:7 Page:12839-12847
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Guo Jing¹,Xiao Qin¹,Lu Yongzhou¹,Gao Jin¹,Ning Peng²,Jia Chuanlong¹,Cai Yijie¹,Gong Chengchen³,Yao Wei¹,Huang Minghuan¹,Chu Weifang¹,Xu Qiannan¹,Xu Nan¹^ORCID

Affiliation:

1. Department of Dermatology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China

2. Institute for Regenerative Medicine, Institute for Translational Nanomedicine, Shanghai East Hospital, School of Medicine, Tongji University, 1800 Yuntai Road, Shanghai 200123, China

3. Department of Dermatology, Changzheng Hospital, Shanghai 200003, China

Funder

Health Commission of Jiangxi Province

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Shanghai Pudong New Area Health Committee Supervision Institute

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.4c01363

Reference45 articles.

1. Psoriasis

2. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

3. Cardiovascular Risk in Patients With Psoriasis

4. Psoriasis: a possible risk factor for development of coronary artery calcification

5. Role of Oxidative Stress in Various Stages of Psoriasis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molybdenum Nanoparticles Alleviate MC903-Induced Atopic Dermatitis-Like Symptoms in Mice by Modulating the ROS-Mediated NF-κB and Nrf2 /HO-1 Signaling Pathways;International Journal of Nanomedicine;2024-08